← Search & browse all drugs
ANTIINFECTIVES FOR SYSTEMIC USE › ANTIVIRALS FOR SYSTEMIC USE › DIRECT ACTING ANTIVIRALS › Other antivirals
riamilovir
J05AX32
Adult Dosing
- 200 mg orally twice daily for 5 to 7 days for acute viral respiratory infections
- Initiate treatment at the earliest sign of symptoms
Pediatric Dosing
- Safety and efficacy in pediatric patients under 18 years of age have not been established
Indications
- Treatment of influenza and other acute viral respiratory infections
Mechanism of Action
- Acts as an antiviral agent inhibiting viral replication
- Interferes with viral-host cell fusion and intracellular replication processes
Contraindications
- Hypersensitivity to riamilovir or any components of the formulation
- Severe hepatic impairment
- Severe renal impairment
- Pregnancy and lactation
Adverse Reactions
- Nausea
- Vomiting
- Diarrhea
- Headache
- Mild to moderate elevation of liver transaminases
- Allergic skin reactions
Drug Interactions
- Potential interactions with strong CYP450 enzyme inducers or inhibitors
- May alter the efficacy of live viral vaccines
Curated Content: Needs Vetting Before Put to Clinical Use